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Copyright © 200? JCBN Summary Paraoxonase-1 (PON-1), an HDL-associated enzyme has been shown to possess
antioxidant/anti-inflammatory properties and protect against atherogenesis. The aim of the
study was to explore the association of PON-1, with lipids, antioxidant-vitamins and lifestyle
in male subjects with and without angiographically documented coronary artery disease
(CAD) and in healthy volunteers. PON-1 activity was measured spectrophotometrically using
phenyl acetate as substrate. PON-1 and HDL-Cholesterol were significantly lower and lipid
peroxides and triglycerides were higher in CAD patients than in normal coronary and control
subjects. PON-1 activity showed positive association with HDL-C and inverse relation with
lipid peroxides and no association with antioxidant vitamins in healthy subjects. Smoking
habit, alcohol intake and diabetes mellitus did not seem to influence PON-1 activity. Serum
levels of PON-1 and HDL-C showed inverse association with the presence of CAD but are not
related to the severity of disease in terms of number of diseased vessels. Interventional means
by diet/drugs to enhance PON-1 activity may contribute to attenuation of atherosclerosis.
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Introduction
Atherosclerosis, the fundamental cause of majority of
heart attacks, is a disease of chronic inflammation and lipid
accumulation. Although the precise mechanisms involved in
coronary artery disease (CAD) are not clear, current theory
predicts that it is caused by an inflammatory response of
arterial wall macrophages to oxidized low-density lipo-
protein (LDL) [1, 2]. Oxidative modification of LDL in the
artery wall is now widely regarded as playing an important
role in the initiation and progression of atherosclerosis.
High-density lipoprotein (HDL), on the other hand, normally
plays an anti-atherogenic role. The protective capacity of
HDL has been ascribed primarily to its ability to remove
excess cholesterol from peripheral tissues in the reverse
cholesterol transport pathway. Recent studies have sug-
gested more diverse mechanisms. HDL inhibits LDL-
oxidation [3, 4] and this may contribute to inverse associa-
tion between plasma HDL levels and risk of developing
CAD. These protective effects of HDL have been attributed
to the various proteins associated with HDL. Paraoxonase-1
(PON-1) is one such protein that had been reported to
possess antioxidant/anti-inflammatory properties [5].
PON-1, an aryldialkylphosphatase EC 3.1.8.1, is an ester
hydrolase associated with HDL in blood [6]. It is well
established that human serum PON-1 catalyzes the hydro-
lysis of toxic organophosphate insecticides, nerve gases, and
aromatic carboxylic acid esters and oxidized phospholipids.
The hydrolysis of oxidized phospholipids by PON-1 destroys
the biologically active lipids in oxidized LDL. This action
of PON-1 could delay the development of atherosclerosis.
There is growing evidence that reduced activity of HDL-
associated PON-1 is predictive of vascular disease in humansParaoxonase-1 and Coronary Artery Disease
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[2, 7–9] including results from prospective studies [10]. A
role of PON-1 in vascular disease is also strongly supported
by knockout and transgenic mouse studies [11, 12]. However
the precise mechanism by which PON-1 influence the risk of
vascular disease is not yet completely known. Its activity is
inactivated by oxidized LDL and preserved by antioxidants
[7]. Unlike chain-breaking antioxidants, HDL prevents the
accumulation of lipid peroxides in LDL and in the vessel
wall for several hours, continuing to do so long even after
fat-soluble antioxidants have been exhausted and this activity
seems to be due to PON-1 [13].
There is an enormous (~40 fold) variation in serum PON-1
activity between individuals due in part, to common poly-
morphism [14]. A variety of external factors, such as anti-
oxidants, fatty foods, lifestyle etc, can also positively as well
as negatively influence the activity of human PON-1. The
serum concentration of HDL-cholesterol has long been
known to have an inverse association with the development
of atherosclerosis that was confirmed by our previous
studies conducted on CAD patients [15, 16]. In addition,
enhanced oxidative stress and altered antioxidant enzymes,
mainly super oxide dismutase, have been found in CAD
patients during stable and unstable anginal syndromes [16].
In view of these, the aims of the present study were to
explore the relationship between serum Paraoxonase-1 and
oxidants/antioxidant-vitamins, lipids, lipoproteins and life-
style habits in male subjects having established CAD and
non-CAD as well as to determine the association of PON-1
with the extend of coronary artery disease.
Patients and Methods
Patients included in this study were the ones admitted in
the Cardiology ward of this Institute for coronary angio-
graphy as a confirmatory test for coronary artery disease.
Male patients from the age of 25–60 years, who were not
taking any lipid lowering drugs and vitamin supplementa-
tion at the time of admission, were recruited for this study.
Patients having other types of heart disease, such as valvular
heart disease, cardiomyopathies etc as well as those having
renal and hepatic diseases were also excluded. Based on the
angiographic reports patients were categorized into two
groups as having coronary artery disease [CAD, n = 284]
and normal coronary [non-CAD, n = 45]. Details of patients
recorded at the time of admission include age, sex, height,
weight, smoking habits, and history of diseases-diabetes
mellitus, hypertension and medication. All patients were
receiving standard drugs-nitrates, β-blockers and/or calcium
channel blockers for the treatment of angina and hyper-
tension. Those having diabetes were receiving oral hypogly-
cemic drugs. Male healthy volunteers (n = 245) from the
hospital staff and their relatives who were free of any
symptoms of chest pain were included as controls for this
study. Lack of CAD was assessed by use of a health
questionnaire and all had no history suggestive of CAD.
Prior informed written consent was obtained from all
subjects for examining blood samples and providing details
regarding health and lifestyle habits required for the study as
per our Institute’s human research ethical guidelines.
Blood sampling
Venous blood sample were obtained from all subjects
in the morning after an overnight fast of ~12 h. Serum was
collected by low speed centrifugation and subjected to
various biochemical analyses.
Analytical methods
Serum lipids. Serum total cholesterol and HDL-cholesterol
(after centrifugation of apo-B containing lipoproteins) were
determined by the recommended CHOD-PAP method using
enzyme assay kits (Olympus Life and Material Science
Europa GmbH, Germany). Serum triglycerides were mea-
sured by the enzymatic GPO-PAP method. LDL-cholesterol
was calculated according to the Friedewald’s formula [LDL-
C = total cholesterol – (HDL-C + Triglycerides/5) mg/dl].
The concentration of oxidants as lipid peroxides in serum
was quantitated by the thiobarbituric acid method using
malondialdehyde as standard [17].
Antioxidant vitamins. Vitamin-E, C and β-carotene were
quantitated by recommended spectrophotometric and spectro-
fluorimetric methods [18–20]. Vitamin-E quantification in-
volved saponification of serum in the presence of pyrogallol
to prevent destruction of tocopherol by alkali and extraction
of tocopherol in hexane. The specific fluorescence of
tocopherols in hexane extract was measured at wavelengths,
excitation 286 nm and emission 350 nm, using FP-750
spectrofluorometer (Jasco, Tokyo, Japan). Vitamin-C/
Ascorbic acid determination depended on the reduction of
ferric ion to ferrous ion by ascorbic acid and the ferrous
ion was determined as the red–orange α,α-dipyridyl chro-
mophore at 525 nm using UV-VIS-1601 spectrophotometer
(Shimadzu, Kyoto, Japan). For quantitating β-carotene, an
extract of the serum in petroleum ether was prepared and
the absorbance was monitored at 450 nm against a standard
of crystalline β-carotene using a spectrophotometer.
Paraoxonase-/arylesterase activity. PON-1 activity was
measured using phenyl acetate as substrate [21]. Briefly, an
aliquot of serum was added to a reaction mixture consisting
of 4 mMol/liter phenyl acetate in 50 mMol/liter Tris acetate
buffer, pH 7.8, containing 20 mMol/liter calcium chloride.
The rate of hydrolysis of phenyl acetate was monitored at
270 nm in a spectrophotometer using a molar absorption
coefficient at 270 nm of 1310 liter. Mol−1.cm−1.N. Jayakumari and G. Thejaseebai
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Statistical analysis
Difference between means was assessed with the students
t test. Value of p less than 0.05 was considered statistically
significant. The Chi-squared tests as well as Pearson correla-
tion coefficient (r) were also used to evaluate the strength of
any association between different variables.
Results
Basic characteristics of the subjects in the three groups,
namely controls, CAD and normal coronary are presented in
Table 1. Compared with controls and normal coronary, CAD
group had greater proportions of smokers, hypertensives and
diabetics. The prevalence of smoking was comparatively
lower in normal coronary group than in CAD patients and
controls. However, the proportion of subjects with diabetes
mellitus, hypertension and overweight were much higher in
normal coronary group than in controls and lower than that
of CAD group.
Table 2 shows the mean values of serum total cholesterol,
triglycerides, LDL-cholesterol and HDL-cholesterol for the
three study groups. Compared with controls and normal
coronary groups, CAD patients had significantly lower
levels of HDL-Cholesterol (p<0.001) and higher levels of
triglycerides (control vs CAD; p<0.001). There was no
significant difference between CAD and normal coronary
subjects in terms of total cholesterol and LDL-cholesterol.
But these levels were significantly lower in CAD when
compared to controls (p<0.05). We found that the subjects
participated as controls had an increased mean level of total
cholesterol (220 mg%) than the reference value for total
cholesterol (200 mg%), may be due to unrestricted dietary
habits. Further, the ratio of total cholesterol to HDL-
Cholesterol (a better risk indicator) was found to be higher
(p<0.001) in CAD group (6.2 ± 2.0) than that of controls
(5.3 ± 1.7) and normal coronary group (5.3 ± 1.97).
Status of PON-1 activity in serum together with the levels
of three major antioxidant vitamins-E, -C and β-carotene, as
well as lipid peroxides are given in Table 3. Mean activity
of PON-1 measured, as arylesterase was significantly lower
Table 1. Basic Characteristics of the study participants
control CAD Normal coronary
Male subjects (n) 245 284 45
Mean age (yrs) 44 ± 10.2 51 ± 6.9 49 ± 8.2
Cigarette smoking (%) 17 65 9
Diabetics Mellitus (%) 13 39 20
Hypertension (%) 13 41 25
Overweight [BMI (Kg/m2)≥25] (%) 31 50 44
Table 2. Serum concentrations of lipids and lipoproteins in subjects with coronary artery disease, normal coronary and controls
(mean ± SD.mg%)
control vs CAD a = p<0.001 & b = p<0.01; Control vs normal coronary b = p<0.01; CAD vs normal coronary a = p<0.001
Total Cholesterol Triglycerides LDL-C HDL-C
Control (n = 245) 220 ± 44 141 ± 68 149 ± 38 42 ± 9.5
CAD (n = 284) 206 ± 42a 164 ± 72a 140 ± 40b 33 ± 7.7aa
Normal Coronary (n = 45) 204 ± 59 148 ± 79 137 ± 51 38 ± 9.4b
Table 3. Paraoxonase-1 activity and oxidant/antioxidant vitamin status in subjects with coronary artery disease, normal coronary and
controls (mean ± SD)
control vs CAD a = p<0.001 & b = p<0.01; CAD vs normal coronary c = p<0.05
Control (n = 245) CAD (n = 284) Normal Coronary (n = 45)
Paraoxonase-1 (kU/L) 100 ± 22 88 ± 25a c 96 ± 22
Lipid peroxides as Malondialdehydes (nM/ml) 1.85 ± 0.51 2.12 ± 0.61a c 1.88 ± 0.65
Vitamin E (μg/dl) 16 ± 6.5 16 ± 4.8 17 ± 5.4
Vitamin C (Mg/dl) 0.62 ± 0.29 0.52 ± 0.27a 0.55 ± 0.29
β-Carotene (μg/dl) 102 ± 34 91 ± 41a 92 ± 36Paraoxonase-1 and Coronary Artery Disease
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in CAD group than that of normal coronary (p<0.05) and
control group (p<0.001). On the other hand CAD patients
had significantly higher levels of lipid peroxides, an index of
oxidative stress compared to normal coronary (p<0.05) and
controls (p<0.001). Among the antioxidant vitamins, (except
vitamin-E) vitamin-C and β-carotene levels were signifi-
cantly lower in patients having CAD than in controls
(p<0.001). As in CAD group, these vitamin levels were
found to be lower in normal coronary group than that of
controls, but the difference was not significant statistically,
may be due to smaller sample size in normal coronary group.
The distributions of PON-1 along with lipid peroxides
were analyzed in CAD and non-CAD subjects as a function
of the status of diabetes mellitus. There was no significant
difference in PON-1 activity between diabetics and non-
diabetics among CAD, normal coronary and control groups.
However, the levels of lipid peroxides were found enhanced
in diabetics compared to non-diabetics in control [DM+
2.02 ± 0.52 (n =3 5 )  v s  D M − 1.80 ± 0.60 (n = 212), p<0.05],
normal coronary [DM+ 2.13 ± 0.56 (n = 9) vs DM− 1.72 ±
0.53 (n =3 6 ) ,  p<0.05] and CAD groups [DM+ 2.25 ± 0.59
(n = 112) vs DM− 2.12 ± 0.63 (n = 172) not significant].
Irrespective of diabetic status CAD patients had remarkably
higher levels of lipid peroxides than that of non-diabetic
controls.
Data from the control group was further analyzed to see
the possible influence of lifestyle factors such as cigarette
smoking and alcohol intake as well as diabetes mellitus on
PON-1 activity, HDL-cholesterol and lipid peroxide levels.
From the Fig. 1, it was obvious that alcohol intake alone
slightly enhanced the activity of PON-1 (did not attain
statistical significance) compared to non-users with a
concomitant increase in lipid peroxide (p<0.001) and no
alteration in HDL-cholesterol level. But, smoking habit
seemed to depress the level of HDL-cholesterol (p<0.05)
and enhance levels of lipid peroxides (p<0.001). Briefly,
alcohol intake, smoking habits and diabetes mellitus among
controls adversely influenced the oxidative stress. But,
these risk factors did not influence serum PON-1 activity.
In this study population PON-1 activity was found varied
from 26 to 170 kU/liter. When the three-study groups were
further categorized according to PON-1 activity in tertiles,
as lowest [PON <84], middle [PON 84–104] and highest
category [PON ≥105], remarkable differences in the distri-
bution of subjects were observed. It was observed that more
subjects in the CAD group (45%) belong to lowest (first)
PON-1 tertile. The corresponding proportions in the control
(22%) and normal coronary (22%) groups were much lower.
On the other hand, more subjects both from the control
(second tertile = 35% & third tertile = 43%) and normal
coronary groups (second tertile = 39% & third tertile = 39%)
were found distributed in the middle and highest PON-1
tertiles and it was only 30% and 25% respectively in the case
of CAD group. These differences are statistically significant
[p<0.01, Chi-square], and indicating inverse association of
PON-1 activity with CAD.
In order to see the influence of biochemical variables
on PON-1 activity we have analyzed the association of
Fig. 1. Influence of risk factors such as diabetes mellitus, smoking habit and alcohol intake on (a) PON-1 activity, (b) HDL-cholesterol
and (c) lipid peroxides among control subjects.N. Jayakumari and G. Thejaseebai
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HDL-cholesterol, lipid peroxides (Fig. 2), and antioxidant
vitamins-E, -C & β-carotene with PON-1 activity in tertiles
in control subjects. As expected, the mean levels of HDL-
cholesterol showed significant positive association and lipid
peroxides showed negative association with PON-1 activity
in tertiles, although there was no significant correlation (r)
between PON-1 and HDL-cholesterol and PON-1 and lipid
peroxides. Further, we have also found no association
between PON-1 tertile activity and corresponding levels of
antioxidant vitamins-E, -C and β-carotene (data not shown).
The associations of PON-1 activity and HDL-Cholesterol
with the severity of coronary artery disease in terms of
number of diseased vessels as one-, two- and three-vessel
coronary artery disease based on angiographic reports
were further analyzed in patients. All the patients with
proven coronary artery disease were found to have reduced
PON-1 activity [1-vessel disease 88 ± 24 (n = 100); 2-vessel
disease 89 ± 25 (n = 89); 3-vessel disease 88 ± 26 (n = 95)
vs normal coronary 96 ± 22 (n =4 5 ) ,  p<0.05]] and HDL-
cholesterol [1-vessel disease 32 ± 8.3; 2-vessel disease
34 ± 7.7; 3-vessel disease 34 ± 9.6 vs normal coronary
38 ± 9.4; p<0.001, 0.01 & 0.05 respectively] compared to
that of normal coronary subjects. However we could not
observe any difference in these two variables as the disease
progressed from one-vessel to two- or three-vessel disease
indicating lack of association with the extend of coronary
artery disease.
Discussion
In the present study we have demonstrated that PON-1
activity and HDL-cholesterol are significantly reduced in
subjects with angiographilly proven coronary artery disease
compared to normal coronary and control subjects. This
finding is in agreement with the reports that have found
reduced PON-1 activities in CAD [8–10]. This effect was
also reported to be independent of PON-1 genotype [9, 22].
PON-1 activity measured using phenyl acetate as substrate
has been thought to be more closely reflecting PON-1
concentration and it minimizes the risk of genotype varia-
tion. Its activity can be decreased in subjects either due to
decreased synthesis or inactivation under oxidative stress by
lipid peroxides. In support of this concept we have observed
an enhanced oxidative stress in CAD patients as character-
ized by increased levels of lipid peroxides.
The activity of PON-1 can be influenced by acquired
factors such as diet, life style and diseases. Most studies [23,
24], but not others [25], have found that PON-1 activity is
reduced in Type-1 and Type-2 diabetic patients. In our study
there was no significant difference in PON-1 activity
between diabetics and non-diabetics with and without CAD.
This finding does not support the concept that PON-1 plays
an important role in predisposition of subjects to diabetes
mellitus. In addition, we could not observe any association
between PON-1 and cigarette smoking habits in control
subjects, although HDL-cholesterol was found decreased in
smokers. To better confirm this finding, future study in a
large number of healthy subjects need to be conducted.
It has been suggested that consumption of red wine or
flavonoid containing drinks [26] as well as moderate alcohol
intake [27] increased serum PON-1 activity. In agreement
with this we also found a slight positive association between
serum PON-1 activity and alcohol consumption in control
subjects. However, the beneficial effect of alcohol intake
was not evident in the levels of HDL-cholesterol or lipid
peroxides. Surprisingly alcohol intake enhanced the lipid
peroxides leading to oxidative stress. So, one possibility for
the enhanced PON-1 activity observed in alcohol users
might be an adaptive enzyme induction to limit the excess
oxidative stress and thus suggesting an important physio-
logical role of PON-1 in host defense.
PON-1, an anti-oxidant enzyme, circulates in blood in
Fig. 2. Influence of biochemical variables such as (a) HDL-cholesterol and (b) lipid peroxides on PON-1 activity in tertiles among
control subjects.Paraoxonase-1 and Coronary Artery Disease
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association with HDL particle and hence HDL is likely to be
an important determinant of PON-1 activity. In support of
this, we have observed a direct relationship between mean
HDL-Cholesterol levels and tertiles of PON-1 activity in
controls, although there is no significant correlation (r)
between PON-1 and HDL-cholesterol. This can be explained
partly by the fact that certain other HDL characteristics such
as particle size, surface phospholipids, and apoproteins are
most important to hold and stabilize PON-1 in HDL particle.
Oxidants are products of normal metabolism and inflam-
matory response. Inactivation and removal of these reactive
oxygen species depend on reaction involving antioxidant
defense systems, which constitute a diverse group of
compounds with different properties. In this study, patients
with CAD were found to have inadequate antioxidant status
as evidenced by lower concentrations of PON-1, vitamin C,
and β-carotene. Lipid peroxides that are substrates as well as
inhibitors of PON-1 activity were found enhanced in
smokers, alcohol users, diabetics and CAD patients. But we
could observe depressed PON-1 activity only in patients
with established CAD. This could be a combined effect of
inadequate antioxidant capacity, excess oxidative stress and
inflammatory response that are prevalent in patients with
CAD. The lower activity of PON-1 can depress the ability of
circulating HDL particle to protect LDL from oxidation, to
participate in reverse cholesterol transport pathway, and
to inhibit monocyte-endothelial cell interaction. All these
appear to be important in the inflammatory response in
artery that promotes atherogenesis. This study indicates that
low activity of PON-1 can enhance one’s risk of developing
atherosclerotic heart disease. Hence preserving or even
increasing PON-1 activity by interventional means such as
drugs or diet rich in flavonoids and antioxidant vitamins
may be beneficial in reducing the risk of CAD.
In conclusion, this study demonstrates that PON-1 activity
and HDL-cholesterol are lower in subjects with angio-
graphically documented coronary artery disease than in
subjects with normal coronary and healthy volunteers.
Further, serum levels of PON-1 and HDL-cholesterol show
inverse association with the presence of coronary artery
disease but not to the severity of coronary disease in terms
of number of diseased vessals.
Acknowledgments
The authors wish to thank the Director, Sree Chitra
Tirunal Institute for Medical Sciences and Technology,
Trivandrum, India for providing necessary facilities to carry
out the work. The authors would also like to thank Professor
J.M. Tharakan, Head of the Dept of Cardiology of this
Institute for providing the blood samples and relevant
clinical details of the patients.
References
[1] Ross, R.: Atherosclerosis an inflammatory disease. New Engl.
J. Med., 340, 115–118, 1999.
[2] Watson, A.D., Berliner, J.A., Hama, S.Y., La Du, B.N., Fuall,
K.F., Fogelman, A.M., and Navab, M.: Protective effect of
HDL-paraoxonase: inhibition of the biological activity of
minimally oxidized LDL. J. Clin. Invest.,  96, 2882–2891,
1996.
[3] Mackness, M.I., Arrol, S., and Durrington, P.N.: Paraoxonase
prevents accumulation of lipid peroxides in LDL. FEBS
Lett., 286, 152–154, 1991.
[4] Mackness, M.I., Abott, C.A., Arrol, S., and Durrington, P.N.:
The role of HDL and lipid soluble antioxidant vitamins in
inhibiting LDL oxidation. Biochem. J., 294, 829–835, 1993.
[5] Durrington, P.N., Mackness, B., and Mackness, M.I.: Para-
oxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol.,
21, 473–480, 2001.
[6] Mackness, M.I., Mackness, B., Durrington, P.N., Connelly,
P.W., and Hegele, R.A.: Paraoxonase: Biochemistry, genetics
and relationship to plasma lipoproteins. Curr. Opin. Lipidol.,
7, 69–76, 1996.
[7] Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson,
R., Bisgaier, C.L., Newton, R.S., and La Du, B.: Human
serum paraoxonase is inactivated by oxidized LDL and
reserved by antioxidants. Free Radic. Biol. Med., 26, 892–
904, 1999.
[8] Ayub, A., Mackness, M.I., Arrol, S., Mackness, B., Patel, J.,
and Durrington, P.N.: Serum paraoxonase after myocardial
infarction.  Arterioscler. Thromb. Vasc. Biol.,  19, 330–335,
1999.
[9] Mackness, B., Davies, G.K., Turkie, W., Lee, E., Roberts,
D.H., Hills, E., Roberts, C., Durrington, P.N., and Mackness,
M.I.: Paraoxonase status in coronary artery disease: are
activity and concentration more important than genotype?
Arterioscler. Thromb. Vasc. Biol., 21, 1451–1457, 2001.
[10] Mackness, B., Durrington, P., McElduff, P., John, Y., Naheed,
A., Michael, W., and Michael, M.: Low paraoxonase activity
predicts coronary events in the Caerphelly prospective study.
Circulation, 107, 2775–2779, 2003.
[11] Shih, D.M., Gu, L., Xia, Y.R., Navab, M., Li, W.F., Hama, S.,
Castellani, L.W., Furlong, C.E., Costa, L.G., Fogelman,
A.M., and Lusis, A.J.: Mice lacking serum paraoxonase are
susceptible to organophosphate toxicity and atherosclerosis.
Nature, 394, 284–287, 1998.
[12] Tward, A., Xia, Y.-R., Wang, X.-P., Shi, Y.-S., Park, C.,
Castellani, L.W., Lusis, A.J., and Shih, D.M.: Decreased
Atherosclerotic Lesion Formation in Human Serum Para-
oxonase Transgenic Mice. Circulation, 106, 484–490, 2002.
[13] Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S.,
Hoffman, A., Billicke, S., Draganov, D., and Rosenblat, M.:
Human serum Paraoxonase Q and R selectively decrease
lipid peroxides in human coronary and carotid atherosclerotic
lesions: PON-1 esterase and peroxides-like activities. Circu-
lation, 101, 2510–2517, 2000.
[14] Player, J.R., Eza, L.C., Bullen, M.F., and Evans, D.A.P.:
Genetic polymorphism and inter-ethnic variability of plasmaN. Jayakumari and G. Thejaseebai
J. Clin. Biochem. Nutr.
284
paraoxonase-1 activity. J. Med. Genet., 13, 337–342, 1976.
[15] Jayakumari, N., Ambikakumari, V., Balakrisgnan, K.G., and
Iyer, K.S.: Distribution of cholesterol in HDL and its sub
fractions in patients with coronary atherosclerotic heart
disease. Ind. Heart J., 45, 265–268, 1993.
[16] Jayakumari, N., Ambikakumari, V., Balanrishnan, K.G., and
Iyer, K.S.: Antioxidant status in relation to free radical
production during stable and unstable anginal syndromes.
Atherosclerosis, 94, 183–190, 1992.
[17] Beuge, J.A. and Aust, S.D.: Thiobarbituric acid assay for
lipid peroxides. Methods Enzymol., 52, 306–310, 1978.
[18] Desai, D.: Vitamin E analysis, methods for animal tissues.
Methods Enzymol., 105, 138–147, 1984.
[19] Omaye, S.T., Turnbull, J.D., and Sauberlich, H.E.: Selected
methods for the determination of ascorbic acid in animal
cells, tissues and fluids. Methods Enzymol., 62, 9–11, 1979.
[20] McCormick, D.B.: Vitamins: Methods for determination of
vitamin A and β-carotene, in Textbook of Clinical Chemistry,
ed. By N.W., Tietz, W.B, Saunders company, West Washington
square, Philadelphia, 932–934, 1986.
[21] Lorenz, K., Flatter, B., and Augustine, E.: Aryl esterase in
serum: Elaboration and clinical application of fixed incuba-
tion method. Clin. Chem., 25, 1714–1720, 1979.
[22] Jarvick, G.P., Hatsukami, T.S., Carlson, C., Richter, R.J.,
Jampsa, R., Brophy, V.H., Margolin, S., Rieder, M.,
Nickerson, D., Schellenberg, G.D., Heagerty, P.J., and
Furlong, C.E.: Paraoxonase activity, but not haplotype utiliz-
ing the linkage disequilibrium structure, predicts vascular
disease. Arterioscler. Thromb. Vasc. Biol.,  23, 1465–1471,
2003.
[23] Boemi, M., Leviev, I., Sirolla, C., Pieri, C., Marra, M., and
James, R.W.: Serum paraoxonase is reduced in type 1 diabetes
compared to non-diabetic, first-degree relatives: Influence
of the ability of HDL to protect LDL from oxidation.
Atherosclerosis, 155, 229–235, 2001.
[24] Agachen, B., Yilmaz, H., Karaali, Z., and Ishir, T.: Para-
oxonase 55 and 192 polymorphism and its relationship to
serum paraoxonase activity and lipids in urkish patients
with non-insulin dependent diabetes mellitus. Cell Biochem.
Funct., 22, 163–168, 2004.
[25] Kopprasch, S., Pietzch, J., Kuhlish, E., and Graessier, J.:
Lack of association between serum paraoxonase activities
and increased oxidation of LDL in impaired glucose
tolerance and newly diagnosed diabetes mellitus. J. Clin.
Endocrinol. Metab., 88, 1711–1716, 2003.
[26] Aviram, M., Domfeld, L., Rosenblat, M., Volkova, N.,
Kaplan, M., Coleman, R., Hayek, T., Presser, D., and
Fubrman, B.: Pomegranate juice consumption reduces oxida-
tive stress, atherogenic modification of LDL and platelet
aggregation: Studies in human and atherosclerotic apo-E
deficient mice. Am. J. Clin. Nutr., 71, 1062–1076, 2000.
[27] van der Gaag, M.S., van Tol, A., Scheek, L.M., James, R.W.,
Urgert, R., Schaafsma, G., and Hendriks, H.F.: Daily
moderate alcohol consumption increases serum paraoxonase
activity, a diet-controlled, randomized intervention study in
middle-aged men. Atherosclerosis, 147, 405–410, 1999.